Skip to main content
Premium Trial:

Request an Annual Quote

EditCo Bio Knockout CD8+ T-Cell Pools

EditCo Bio has launched Knockout CD8+ T-cell Pools for primary T-cell editing. Building upon the company's Knockout CD4+ T-cell Pools, the new product enables researchers to bypass challenging optimization steps and access highly functional edited T-cells for immediate use, EditCo said. The seven-day protocol and proprietary guide RNA technology yields knockout efficiencies approaching 100 percent in primary human CD8+ T cells. Additionally, EditCo said it has several prescreened and optimized donor cells available.